RMNI vs RPAY

RMNI presents a contradictory profile: while the Piotroski F-Score of 7/9 suggests strong operational health, this is overshadowed by a severe collapse in earnings growth (-99.10% YoY) and negative revenue growth. The company is trading at $3.72, a significant premium to its growth-based intrinsic value of $2.73, and exhibits critical liquidity concerns with a current ratio of 0.86. Aggressive insider selling by the CEO and CFO, combined with four consecutive quarterly earnings misses, indicates a lack of internal confidence despite a low P/E ratio.

RPAY exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the stock appears cheap on a Price-to-Book (0.69) and Forward P/E (4.41) basis, these metrics are overshadowed by a catastrophic -3320% YoY earnings collapse and a profit margin of -83.01%. Stagnant revenue growth (0.40%) and a current ratio below 1.0 (0.82) suggest significant liquidity risks and a lack of growth catalysts. Despite a bullish analyst consensus, the combination of a 0/100 technical trend and negative earnings surprises makes this a high-risk value trap.